INTERNATIONAL PATENT: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE, ASSISTANCE PUBLIQUE-HÔPITAUX DE PARIS (APHP), CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, UNIVERSITE PARIS CITE, PUISSANT, ALEXANDRE FILES APPLICATION FOR "COMBINATION OF PAK1 INHIBITORS AND CLK INHIBITORS FOR PREVENTING RESISTANCE TO CHEMOTHERAPY IN PATIENTS SUFFERING FROM ACUTE MYELOID LEUKEMIA"

GENEVA, April 19 -- INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (101, rue de Tolbiac75013 Paris), ASSISTANCE PUBLIQUE-HÔPITAUX DE PARIS (APHP) (55 boulevard Diderot75012 Paris), CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (3, Rue Michel Ange75016 Paris), UNIVERSITE PARIS CITE (85 Boulevard Saint-Germain75006 Paris), PUISSANT, Alexandre (HOPITAL ST LOUIS - U944 Equipe MMAD - 16, rue de la Grange aux belles75010 PARIS) filed a patent application (PCT/EP2024/078209) for "COMBINATION OF PAK1 INHIBITORS AND CLK INHIBITORS FOR PREVENTING RESISTANCE TO CHEMOTHERAPY IN PATIENTS SUFFERING FROM ACUTE MYELOID LEUKEMIA" on Oct 08, 2024. With publication no. WO/2025/078334, the details related to the patent application was published ...